Cargando…
Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer’s related amyloid-beta pathology
The blood-brain barrier (BBB) presents a major obstacle in developing specific diagnostic imaging agents for many neurological disorders. In this study we aimed to generate single domain anti-mouse transferrin receptor antibodies (anti-mTfR VHHs) to mediate BBB transcytosis as components of novel MR...
Autores principales: | Su, Shiran, Esparza, Thomas J., Brody, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578589/ https://www.ncbi.nlm.nih.gov/pubmed/36256604 http://dx.doi.org/10.1371/journal.pone.0276107 |
Ejemplares similares
-
Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody
por: Esparza, Thomas J., et al.
Publicado: (2023) -
Pathogenic bacteria exploit transferrin receptor transcytosis to penetrate the blood–brain barrier
por: Cheng, Zhihui, et al.
Publicado: (2023) -
Standardized
Preclinical In Vitro Blood–Brain Barrier Mouse
Assay Validates Endocytosis-Dependent
Antibody Transcytosis Using Transferrin-Receptor-Mediated Pathways
por: Morrison, Jamie I., et al.
Publicado: (2023) -
Affibody Molecules Intended for Receptor-Mediated Transcytosis via the Transferrin Receptor
por: Hjelm, Linnea Charlotta, et al.
Publicado: (2023) -
Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance
por: Zhao, Zhen, et al.
Publicado: (2015)